| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements by Eli Lilly in innovative treatments, particularly in incretin therapies and weight-loss medications, demonstrate a strong potential for market growth and acceptance in the obesity management sector. These developments position the company as a leader in addressing pressing health issues, which is reflected in the high sentiment scores associated with these themes. The recognition of weight-loss drugs as primary treatments showcases a shift towards embracing pharmaceutical solutions for obesity. However, ongoing competition and regulatory challenges may pose hurdles in leveraging these opportunities fully. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.4 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at -0.2 on 2025-10-04. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-04 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-10-03 | 0%(0%) | 0 | 0% | 0.2 | 2.2 | 4 | |||||||
| 2025-10-02 | 0%(0%) | 0 | 0% | 0.2 | 1.9 | -1 | |||||||
| 2025-10-01 | 0%(0%) | 0 | 0% | 0 | 1 | 6 | |||||||
| 2025-09-30 | 0%(0%) | 0 | 0% | -0.1 | 0.3 | -1 | |||||||
| 2025-09-29 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| 2025-09-28 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-09-27 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-09-26 | 0%(0%) | 0 | 0% | 0.1 | 1.4 | 6 | |||||||
| 2025-09-25 | 0%(0%) | 0 | 0% | -0.1 | 0.5 | -6 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-04 17:01:53 Current trading trends suggest a favorable environment for pharmaceutical stocks, including Eli Lilly. |
| 2025-10-04 17:01:53 The market's reaction to Eli Lilly's stock reflects broader investor sentiment towards the pharmaceutical industry. |
| 2025-10-04 17:01:53 Eli Lilly's performance is influenced by its position among competitors, showcasing its competitive advantages in the market. |
| 2025-10-04 17:01:53 The recent trading activity suggests strong earnings potential and a positive outlook for the company's financial health. |
| 2025-10-04 17:01:53 The performance of Eli Lilly's stock indicates positive movement in the market, reflecting investor confidence. |